A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis
Clinical trial NCT02581527 · COMPLETED
Trial details
- NCT number
- NCT02581527
- Sponsor
- St George's, University of London
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2022-01-01
- Enrollment
- 672
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.